Accretion Nutraveda IPO Final Subscription Status

Final subscription data from BSE & NSE with category-wise breakdowns

📈 GMP Today 🎟️ Allotment Status 📄 Full IPO Details Listed at BSE · Registrar: Kfin Technologies Ltd.
Listed SME
Price: ₹122 - ₹129 Lot: 1000 Min: ₹1,29,000 Period: 28 Jan - 30 Jan
Subscribed
1.91x
Total Demand
₹31 Cr
Applications
811
Build by Day
1.91x

Subscription (Shares)

CategoryOfferedAppliedTimes
QIB 3,62,000 3,67,000 1.01
NII 2,76,000 6,69,000 2.42
bNII (>10 Lakh) 1,84,000 4,55,000 2.47
sNII (2-10 Lakh) 92,000 2,14,000 2.33
Retail 6,40,000 14,04,000 2.19
TOTAL 12,78,000 24,40,000 1.91

Application Breakup

CategoryReservedApplicationsTimes
NII 92 334 3.63
bNII (>10 Lakh) 61 57 0.93
sNII (2-10 Lakh) 31 107 3.45
Retail 640 1,404 2.19
TOTAL 824 811 0.98

Subscription (Crores)

CategoryOfferedDemandTimes
QIB 4.67 4.73 1.01
NII 3.56 8.63 2.42
bNII (>10 Lakh) 2.37 5.87 2.47
sNII (2-10 Lakh) 1.19 2.76 2.33
Retail 8.26 18.11 2.19
TOTAL 16.49 31.48 1.91

Day-wise Subscription

End-of-day subscription.

Each panel has its own scale.
Day QIB NII bNII sNII Retail Total
Day 3 30 Jan 1.01x 2.42x 2.47x 2.33x 2.19x 1.91x

Estimated Allotment Chance

Retail 52.1% (2.19x subscribed)
High chance
S-HNI (2-10L) 42.9% (2.33x subscribed)
Moderate chance
B-HNI (>10L) 100.0% (2.47x subscribed)
High chance
about 5 in 10 retail applicants are likely to get allotment.
Estimate from subscription data; the registrar's draw decides.

How Accretion Nutraveda’s demand compares with recent SME IPOs

Final multiples against the 192 SME IPOs listed in the last 12 months.

CategoryAccretion NutravedaSME medianHigher than
Overall 1.91x 4.03x 30% of 192
QIB 1.01x 14.98x 12% of 163
NII (HNI) 2.42x 5.36x 39% of 192
Retail 2.19x 3.58x 33% of 192

Of the 88 recent SME IPOs that finished under 3x subscribed, 31% opened above the issue price, with a median listing-day move of +0%. Accretion Nutraveda itself listed at +48.2%.

Source: BSE and NSE. Not investment advice.

Accretion Nutraveda IPO Subscription — Detailed Analysis

Where Accretion Nutraveda Subscription Finished

Accretion Nutraveda IPO was subscribed 1.91 times overall by the close of bidding — fully covered, indicating decent investor interest. A total of 811 applications were received.

Accretion Nutraveda IPO Subscription — FAQs

Accretion Nutraveda IPO was subscribed 1.91 times overall by the close of bidding.

Accretion Nutraveda IPO was open for subscription from January 28, 2026 to January 30, 2026.

The price band for Accretion Nutraveda IPO is ₹122 - ₹129 per share.

See also: reading the subscription table · allotment chances · allotment process

GMPUpdate